Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists (vol 43, pg 3596, 2000)

被引：0
|
作者：
Ursini, A
Capelli, AM
Carr, RAE
Cassarà, P
Corsi, M
Curcuruto, O
Curotto, G
Dal Cin, M
Davalli, S
Donati, D
Feriani, A
Finch, H
Finizia, G
Gaviraghi, G
Marien, M
Pentassuglia, G
Polinelli, S
Ratti, E
Reggiani, A
Tarzia, G
Tedesco, G
Tranquillini, ME
Trist, DG
Van Amsterdam, FTM
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2000年 / 43卷 / 26期
关键词：
D O I：
10.1021/jm001100i
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：5057 / 5057
页数：1
相关论文
共 10 条
  • [1] Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists
    Ursini, A
    Capelli, AM
    Carr, RAE
    Cassarà, P
    Corsi, M
    Curcuruto, O
    Curotto, G
    Dal Cin, M
    Davalli, S
    Donati, D
    Feriani, A
    Finch, H
    Finizia, G
    Gaviraghi, G
    Marien, M
    Pentassuglia, G
    Polinelli, S
    Ratti, E
    Reggiani, A
    Tarzia, G
    Tedesco, G
    Tranquillini, ME
    Trist, DG
    Van Amsterdam, FTM
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (20) : 3596 - 3613
  • [2] Quantitative structure-activity relationship studies on 5-phenyl-3-ureido-1,5-benzodiazepine as cholecystokinin-A receptor antagonists
    Agrawal, VK
    Sharma, R
    Khadikar, PV
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) : 3571 - 3581
  • [3] 5-PHENYL-3-UREIDOBENZAZEPIN-2-ONES AS CHOLECYSTOKININ-B RECEPTOR ANTAGONISTS
    LOWE, JA
    HAGEMAN, DL
    DROZDA, SE
    MCLEAN, S
    BRYCE, DK
    CRAWFORD, RT
    ZORN, S
    MORRONE, J
    BORDNER, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (22) : 3789 - 3811
  • [4] Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists
    Roberts, Karen
    Ursini, Antonella
    Barnaby, Robert
    Cassara, Paolo G.
    Corsi, Mauro
    Curotto, Giovanni
    Donati, Daniele
    Feriani, Aldo
    Finizia, Gabriella
    Marchioro, Carla
    Niccolai, Daniela
    Oliosi, Beatrice
    Polinelli, Stefano
    Ratti, Emiliangelo
    Reggiani, Angelo
    Tedesco, Giovanna
    Tranquillini, Maria E.
    Trist, David G.
    van Amsterdam, Franciscus T. M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (14) : 4257 - 4273
  • [5] Synthesis and SAR of 5-Amino- and 5-(Aminomethyl)benzofuran Histamine H3 Receptor Antagonists with Improved Potency (vol 48, pg 6482, 2005)
    Sun, Minghua
    Zhao, Chen
    Gfesser, Gregory A.
    Thiffault, Christine
    Miller, Thomas R.
    Marsh, Kennan
    Wetter, Jill
    Curtis, Michael
    Faghih, Ramin
    Esbenshade, Timothy A.
    Hancock, Arthur A.
    Cowart, Marlon
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 563 - 563
  • [6] Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: a preliminary receptor-driven SAR profile
    Pastorin, Giorgia
    Federico, Stephanie
    Cateni, Francesca
    Cacciari, Barbara
    Klotz, Karl-Norbert
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    Corradino, Marta
    Paoletta, Silvia
    Moro, Stefano
    Spalluto, Giampiero
    PURINERGIC SIGNALLING, 2010, 6 (01) : 80 - 80
  • [7] New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists:: synthesis, biological evaluation and molecular modelling studies (vol 3, pg 2262, 2005)
    Fossa, P
    Pestarino, M
    Menozzi, G
    Mosti, L
    Schenone, S
    Ranise, A
    Bondavalli, F
    Trincavelli, ML
    Lucacchini, A
    Martini, C
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (20) : 3826 - 3826
  • [8] Azines and azoles:: CXXVII.: 5-phenyl-7H[1,2,4]triazolo[5,1-b][1,3]thiazin-7-ones:: Synthesis and structure (vol 43, pg 1347, 2007)
    Danilkina, N. A.
    Mikhailov, E.
    Selivanov, S. I.
    Ivin, B. A.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2007, 43 (11) : 1749 - 1749
  • [9] Exploration of the pharmacophore of 3-alkyl-5-arylimidazolidinediones as new CB1 cannabinoid receptor ligands and potential antagonists:: Synthesis, lipophilicity, affinity, and molecular modeling. (vol 45, pg 1750, 2002)
    Ooms, F
    Wouters, J
    Oscari, O
    Happaerts, T
    Bouchard, G
    Carrupt, PA
    Testa, B
    Lambert, DM
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) : 4799 - 4799
  • [10] PHARMACOLOGICAL PROFILE OF (R)-1[2,3-DIHYDRO-1-(2'-METHYL-PHENACYL)-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-3-(3-METHYLPHENYL)UREA (YM022), A NEW POTENT AND SELECTIVE GASTRIN CHOLECYSTOKININ-B RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO
    NISHIDA, A
    MIYATA, K
    TSUTSUMI, R
    YUKI, H
    AKUZAWA, S
    KOBAYASHI, A
    KAMATA, T
    ITO, H
    YAMANO, M
    KATUYAMA, Y
    SATOH, M
    OHTA, M
    HONDA, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (02): : 725 - 731
1